A Review on Packaging for
Different Formulations
Manukondakeerthi*,
Lakshmiprasanna.
J, Santhosh aruna M, Rama Rao N
Chalapathi Institute of
Pharmaceutical Sciences, Lam, Guntur, A.P, India.
*Corresponding Author E-mail: manukondakeerthi23@gmail.com
ABSTRACT:
Encase of all
pharmaceutical products, with a clear information i.e;
label about the information of drug nature, quantity manufacturing date and expiry date, with a clear information on
storage of drugs. Single label shows whole information
about drug. Packaging gives more information for a layman people about the use
of drug. Nowdays packaging development is more
important along with the drug safety. packaging should
be firm and safe up to the end-user of product. Packaging means a blends of science and technology. Packaging area not only
helps in creation of wealth, preserving product quality, but also lengthens the
shelf life of products. Growing demand of packaging in the pharmaceutical
companies there is a demand for packaging professionals for producing
consistent qualitative packaging materials in optimum cost. This review
provides a brief introduction about packaging functions and packaging materials
for different formulations like solid dosage forms, semisolid dosage forms,
oral liquids, parenteral, liposome and transdermal patches.
KEYWORDS: Packaging, Tamper resistant packaging, Liposome’s,
suppositories, packaging
materials.
INTRODUCTION:
Packaging means a collection of different
packaging materials which encase the pharmaceutical product from the time of
manufacturing to the end of the user .encasing of drugs is important for
life-saving drugs, medical devices, medical treatments, and new products like
medical nutritionals. Poultice, liquid, solid, powder, suspension it should be
transparent to the user about its whole information on the drug.[1,2]
different types of pharmaceutical packaging materials are present but it
depends upon its function and type of the material used. Finally packaging
materials are evaluated for sterilization, storage and certain stability
studies. Packaging protects the harmful drugs from children direct contact
because different types of packaging are produced in to market, they can’t
easily open the packaging. [3] Packaging is an
multiple user means provide presentation, protection, identification
information, about a product during storage, carriage, display and until the
product is consumed. [4]
The quality of the packaging
of pharmaceutical products plays a very important role in the quality of such products.
It must [5]
·
protect
against all adverse external influences that can alter the properties of the
product, e.g. moisture, light, oxygen and temperature variations;
·
protect
against biological contamination;
·
protect
against physical damage;
·
Carry
the correct information and identification of the product.
A distinction must be made between primary and secondary packaging
components. The primary packaging components (e.g. bottles, vials, closures,
blisters) are in direct physical contact with the product, whereas the
secondary components are not (e.g. aluminium caps,
cardboard boxes). The choice of primary and/or secondary packaging materials
will depend on the degree of protection required, compatibility with the
contents, the filling method and cost, but also the presentation for
over-the-counter (OTC) drugs and the convenience of the packaging for the user
(e.g. size, weight, method of opening/reclosing (if appropriate), legibility of
printing).Containers may be referred to as primary or secondary, depending on
whether they are for immediate use after production of the finished product or
not. Both single-dose and multi-dose containers exist. Containers may be
well-closed, tightly closed, hermetically closed or light-resistant, airtight.[6]
Table 1:Types
of raw materials used in packaging
Types of materials |
Uses |
Cardboard Boxes Display units |
Boxes Display units |
Paper |
Labels, leaflets |
Glass |
Ampoules Bottles Vials Syringes Cartridges |
Plastic |
Closures Bottles Bags Tubes Laminates with paper or foil |
Metals eg: aluminium |
Collapsible tubes Rigid cans Foils Needles Gas cylinders Pressurized containers |
Rubber |
Closures, including plungers |
Functions of packaging:
Containment:
The containment of the product is the most fundamental function of
packaging for medicinal products. The design of high-quality packaging must
take into account both the needs of the product and of the manufacturing and
distribution system. This requires the packaging:
·
Not to
leak, nor allow diffusion and permeation of the product;
·
To be
strong enough to hold the contents when subjected to normal handling.
·
Not to
be altered by the ingredients of the formulation in its final dosage form.
·
Protection
The packaging must protect the product against all adverse
external influences that may affect its quality or potency, such as:
·
light
·
moisture
·
oxygen
·
biological
contamination
·
Mechanical
damage.
Stability:
Information on stability is given in the guidelines for stability
testing of pharmaceutical products containing well-established drug substances
in conventional dosage forms.
For primary packaging, it is necessary to know the possible
interactions between the container and the contents. Normally,
product/component stability and compatibility are confirmed during the primary
research and development stage. There are numerous possibilities of
interactions between (primary) packaging materials and pharmaceutical products,
such as:
·
The
release of chemicals from components of the packaging materials;
·
The
release of visible and/or sub visible
particles;
·
The
absorption or adsorption of pharmaceutical components by the packaging
materials;
·
Chemical
reactions between the pharmaceutical product and the packaging materials;
·
The
degradation of packaging components in contact with the pharmaceutical
products;
·
The
influence of the manufacturing process (e.g. sterilization) on the container.
Labels:
Throughout manufacturing, a succession of specific outer labels is
applied to the container of the medicinal product. The level of processing is
indicated by the following words:
·
Quarantine
·
Storage
·
Distribution.
Specifications for labels for finished drug products are defined
in the WHO guidelines on GMP for pharmaceutical products .Written labels on the
packaging:
·
Permit
the identification of each active ingredient by means of its INN, and also give
the dosage form and the trade name/trademark. All information concerning the
medicinal product, as required by national legislation, must be stated on the
packaging.
·
Preserve
the stability of the medicinal product by giving advice on its storage
After the stability of the product has been evaluated, one of the
following recommendations as to storage conditions can be prominently indicated
on the label:
·
Store under
normal storage conditions;
·
Store between
2 and 8 °C (under refrigeration, no freezing);
·
Store below
8 °C (under refrigeration);
·
Store between
-5 and -20 °C (in a freezer);
·
Store below
-18 °C (in a deep freezer).
Permit the follow-up of a specific medicinal product by means of
the batch number on the labels. It must be possible to follow the route of
distribution of a product from the manufacturing process to its administration
to the patient with the aim of locating and identifying products that are of
potential risk (e.g. blood products, blood-derived products).
Mask the real identity of the medicinal product in clinical
studies. This is extremely important in clinical trials in determining the real
efficacy of a medicinal product in blinded studies. If the identity is masked
by a code, it must be possible to disclose it at any time in a medical
emergency.
Repacking, relabeling
and dispensing:
In some countries, it is common practice not to dispense drugs in
the original packaging, but rather in a personalized manner to each patient
.This applies especially to solid oral dosage forms, and involves the
“repacking” and “relabeling” of drugs in small quantities. Different drugs may
even be included in “customized” medication packages, also referred to as
“patient med packs”. The quantities of drugs supplied in this way are usually
enough only for a short period of time, i.e. to provide drugs for immediate
use. It should be remembered, however, that data obtained in stability studies
undertaken by the manufacturer are no longer valid for drugs removed from the
original package.
Package inserts for patients
(patient information leaflets):
Product information must help patients and other users to
understand the medication. The patient package insert, together with the label,
provides the patient with key information concerning the proper use of the
product, potential adverse drug reactions and interactions, storage conditions
and the expiry date. In OTC medicinal products, the package insert, together
with the label, may constitute the only pharmaceutical advice that the patient
receives.
Compliance:
Packaging and labeling may help to reinforce the instructions
given by the physician or the pharmacist, and improve compliance with drug
therapy. In this respect, packaging becomes a compliance aid. The design of
pharmaceutical packaging should be such that the product can easily be
administered in a safe manner to the patient. If the patient feels at ease with
the packaging and route of administration, the design of the packaging may
become a key factor in increasing compliance. This is also an important factor
in clinical trials.
Protection of patients:
Packaging must not only increase compliance through its design,
but must also protect the patient and indicate the integrity of the product
.Packaging equipped with a tamper-evident device protects against incidental
and accidental poisoning. To protect children, several child-resistant closures
have been developed. [7]
Packaging materials and
closures [8]
Glass:
For a large number of pharmaceuticals, including medicinal
products for oral and local administration, glass containers are usually the
first choice (e.g. bottles for tablets, injection syringes for unit- or multi
dose administration.
Classifications of types of glass are given in the European and United
States pharmacopoeias, whereas no such classification exists in the Japanese
pharmacopoeia. Glass can be tested for light transmission and hydrolytic
resistance. In the Japanese pharmacopoeia, such tests are described only for
glass containers for injection, whereas in the European and United States
pharmacopoeias they are given for all types of glass containers.
Plastics:
Some containers are now being made of plastics; the main use is
for bags for parenteral solutions. Plastic containers
have several advantages compared with glass containers unbreakable, Collapsible, light
The European, Japanese and United States pharmacopoeias all
describe materials of the same type, but there are considerable differences in
the classification and presentation.
Metal:
Metal containers are used solely for medicinal products for non parenteral administration. They include tubes, packs made
from foil or blisters, cans, and aerosol and gas cylinders. Aluminium
and stainless steel are the metals of choice for both primary and secondary
packaging for medicinal products. They have certain advantages and provide
excellent tamper-evident containers. Metal is strong, impermeable to gases and
shatter proof, it is the ideal packaging material for pressurized containers.
Closures:
Closures used for the purpose of covering drug containers after
the filling process should be as inert as possible. They should not give rise
to undesired interactions between the contents and the outside environment, and
should provide a complete seal. Besides their protective function, closures
must also allow the easy and safe administration of the drug.
Depending on the application, closures may have to be pierced with
a needle for intravenous sets. Such closures are made from elastomeric
materials (rubbers), while those that cannot be pierced are generally made from
plastics such as polyethylene or polypropylene. Depending on the type of
container, closures may have different shapes and sizes, e.g. stoppers for
infusion or injection bottles or plungers for prefilled syringes. A special
design of stopper may also be required for some pharmaceutical production
processes such as lyophilization.
Closures, as primary packaging components, are of critical
importance and must be carefully selected.
Table 2: Examples of Packaging Concerns for common
classes of Drug Products[9]
Degree of
Concern Likelihood of Packaging Component-Dosage Form Interaction Associated
with the Route of Administration |
Likelihood of Packaging Component-Dosage Form Interaction |
||
|
High |
Medium |
Low |
Highest |
Inhalation
Aerosols and Solutions; Injection and Injectable Suspension |
Sterile Powders and Powders for Injection;
Inhalation Powders |
|
High |
Ophthalmic
Solutions and Suspension; Transdermal Ointments and
Patches; Nasal Aerosol and Sprays |
|
|
Low |
Topical
Solutions and Suspensions; Topical and Lingual Aerosols; Oral Solutions and
Suspension |
Topical Powders;
Oral Powder |
Oral Tablets and
Oral (Hard and Soft Gelatin) Capsules |
Packaging material for
different formulations [10]
solid dosage forms:
Tamper resistant
packaging:
The requirement for
tamper resistant packaging is now one of the major consideration
in the development of packaging for pharmaceutical products. Tamper evident
containers are closed containers fitted with a device that
irreversibly indicates if the container has been opened.
The following package configuration have been identified by the FDA as examples
of packaging systems that are capable of meeting the requirements of tamper
resistant packaging as defined by FDA regulation
·
Film
wrappers
·
Blister
package
·
Strip
package
·
Bubble
pack
·
Shrink
seal and bands
·
Foil
paper or plastic pouches
·
Bottle
seals
·
Tape
seals
·
Breakable
caps
·
Sealed
tubes
Strip packages:
A strip package is a form of unit dose
packaging that is commonly used for the packaging of tablets and capsules. A
strip package is formed by feeding two webs of a heat-sealable flexible film
through either a heated crimping roller or a heated reciprocating plate. The
product is dropped into the pocket formed prior to forming the final set of
seals. A continuous strip of packets is formed, generally several packets wide
depending on the packaging machine's limitations. The strip of packets is cut
to the desired number of packets in length. The strips formed are usually
collated and packaged into a folding carton. The product sealed between the two
sheets of film usually has a seal around each tablet, with perforations usually
separating adjacent packets. The seals can be in a simple rectangular or
"picture-frame" format or can be contoured to the shape of the
product .Different packaging materials are used for strip packaging based on
their properties for high-barrier applications; a
paper/polyethylene/foil/polyethylene lamination is commonly used.
Blister packages
When one thinks of
unit dose in pharmaceutical packaging, the package that invariably comes to
mind is the blister package. This packaging mode has been used extensively for
pharmaceutical packaging for several good reasons. It is a packaging
configuration capable of providing excellent environmental protection, coupled
with an esthetically pleasing and efficacious appearance. It also provides user
functionality in terms of convenience, child resistance, and no, tamperresistance.
The blister package
is formed by heat-softening a sheet of thermoplastic resin and vacuum-drawing
the softened sheet of plastic into a contoured mold. After cooling, the sheet
is released from the mold and proceeds to the filling station of the packaging
machine. The semi-rigid blister previously formed is filled with product and
lidded with a heat-sealable backing material. The backing material, peelable type is usually heat-seal-coated aluminum foil.
The coating on the foil must be compatible with the blister material to ensure
satisfactory sealing, both for product protection and for tamper resistance.
Materials commonly used for the thermo-formable blister are poly vinyl chloride
(PVC), PVC/polyethylene combinations, polystyrene, and polypropylene. In
tropical areas blister packages with an additional aluminium
membrane is used which provide greater protection against high humidity
Child Resistant
Containers commonly
referred to as CRC's, are designed to prevent the child accessing the potentially
hazardous product.
Bubble Pack:
The bubble pack can be made in several ways
but is usually formed by sandwiching the product between a thermo formable,
extensible, or heat-shrinkable plastic film and a rigid backing material. This
is generally accomplished by heat-softening the plastic film and vacuum-drawing
a pocket into the film in a manner similar to the formation of a blister in a
blister package. The product is dropped into the pocket, which is then sealed
to a rigid material such as heat-seal-coated paperboard. If a heat-shrinkable
material is used, the package is passed through a heated tunnel, which shrinks
the film into a bubble or skin over the product, firmly attaching it to the
backing card.
Film
wrapper:
A transparent film
with a distinctive design is wrapped securely around a product or product
container. The film must be cut or torn to open the container and remove the
product. Substrates options include ultra destructible films, voidable films
that provides image when removed. e.g., Solvent sensitive
papers.
Shrink seals and
bands
Bands or wrappers
with a distinctive design are shrunk by heat or drying to seal the cap and
container union. The seal must be cut or torn to remove the product. The shrink
band concept makes use of the heat-shrinking characteristics of a
stretch-oriented polymer, usually PVC. The heat-shrinkable polymer is
manufactured as an extruded, oriented tube in a diameter slightly larger than
the cap and neck ring of the bottle to be sealed.
Breakable caps
Such caps break
when an attempt is made to open it. These caps provide external tamper evidence
and can also be combined with the internal seals thereby providing double
security
Sealed tubes
The mouth of the
tube is sealed, and the seal must be punctured to obtain the product.
.
Shrink
tubing
:
Foil, Paper, or Plastic Pouches
The flexible pouch
is a packaging concept capable of providing not only a package that is
tamper-resistant, but also, by the proper selection of material, a package with
a high degree of environmental protection. A flexible pouch is usually formed
during the product filling operation by either vertical or horizontal forming,
filling, and sealing (f/f/s) equipment.:
Bottle Seals
A bottle may be
made tamper-resister by bonding an inner seal to the rim of the bottle in such
a way that access to the product can only be attained by irreparably destroying
the seal. Various inner seal compositions may be used, but the structures most
frequently encountered are glassine and foil laminations. Typically, glassine
liners are two-ply laminations using two sheets of glassine paper bonded
together with wax or adhesive. The inner seals are inserted into the bottle cap
and held in place over the permanent cap liner by either by applying friction
or by the a slight application of wax which temporarily adheres the seal to the
permanent cap liner. If glue-mounted inner seals are to be used, glue is
applied to the rim of the bottle prior to the capping operation.
Tape Seals:
Tape sealing involves
the application of a glued or pressure-sensitive tape or label around or over
the closure of the package, which must be destroyed to gain access to the
packaged product. The paper used most often is a high-density lightweight paper
with poor tear strength. Labels made of self-destructing paper are available;
these cannot survive any attempt at removal once they have been applied. To
reduce further the possibility of removing the label intact, perforation or
partial slitting of the paper can be made prior to application so that the
label tears readily along those weak points if any attempt is made to remove
it.
Containers for semi solid and pressurized
products [11]
Semi
solid dosage forms like ointments, creams, jell, emulsions, lotions, pastes, poultices.
1.Collapsible Metal and Plastic Tubes:
A Its
narrow orifice prevents serious contamination of unused parts of contents.
B Wastage
is reduced, since the patient is less likely to remove an excessive amount.
C When
part of the preparation is expelled it is not replaced, as in other containers,
by equivalent volume of air; consequently, microbial contamination and
oxidative or hydrolytic degradation of the remaining contents are reduced.
D Nozzle
type applicators can be fitted to facilitate administration into body cavities
such as nose or vagina.
Most collapsible tubes are made of
aluminum, although tin, lead, tin coated lead and plastics are also used.
Aluminum tubes have good resistance to corrosion because the surface of film of
oxide.
2.Glass Plastic Pots:
Suitable alternatives are wide mouthed
squat, cylindrical pots made from glass or suitable plastics having a plastic
(or occasionally metal) screw (or, sometimes in case of plastics, slip over
cap). Glass pots may either be colorless and either clear or amber color or
opal white. Glass is inert, hygienic and provides stability considerations
allow transparency, the content can be seen. Unless returned by patient for
reuse, they are more expensive than plastics.
Aerosols:
Pressurized packages expel the product through a valve. The pressure exerted
for the expulsion of the product is an important consideration while selecting
the packaging for any products.
Packaging of therapeutic
active ingredients in a pressurized system. Aerosols are depends on the power of
compressed or liquefied gas to expel the contents from containers. A dose can
be removed without contamination of materials. Stability is enhanced for these
substances adversely affected by oxygen and or moisture. When sterility is an important
factor, it can be maintained while a dose is being dispensed.
Containers:
They must be stand at pressure as high as
140 to 180 psig (pounds per sq. inch gauge) at 1300 F. Containers are generally made up of glass or
metal. But brittleness restricts the use of glass. If the pressure is less than
25psig and propellant content is less than 15% then glass can be used. Glass
should be coated with plastic coating in two layers if pressure is less than or
equal to 33psig. . Epoxy and vinyl resins can be used as linings. A vinyl
coating on which the epoxy coating is most suitable for products having less
PH.
Tinplated
steel:
It is used for most aerosol
as it is light inexpensive and durable. It is steel that has been plated on both sides with tin.
Tin plated steel containers are of two
types: Two pieces container, three pieces container.
Aluminium:
Aluminium containers are more resistant to corrosion
than tin-plated steel. Aluminium container is made by
an extrusion process and hence has no seam. Aluminium
is subjected to corrosion by water and alcohol.
Containers for liquids Parentrals
Injectable formulations are packaged in to containers made of
plastic or glass. Container system includes ampoules, syringes, vials, bottles,
cartridges, bags ampoules are all glass, and plastic are all bags. Rubber materials for rubber stoppers for vials and bottles, rubber
plungers and rubber seals for syringes, cartridges. Irrigation solutions
are packaged in glass bottles with aluminium screwcaps. [12]
A single-dose container is one that holds a quantity of drug
intended as a single dose and when opened cannot be resealed with assurance
that sterility has been maintained. These containers include fusion-sealed
ampoules and prefilled syringes and cartridges
Single dose containers
Hold the product that is intended for
single use. An example of such a container is the glass ampoule.
Multi dose containers
A multiple-dose container is a hermetic container that permits
withdrawal of successive portions of the contents without changing the strength
or endangering the quality or purity of the remaining portion (vials). The
device is usually a spoon or a cup of volume 5ml.
Hold a quantity of the material that will
be used as two or more doses. An example of this system is the multiple doses
vial or the plastic tablet bottle.
Well closed containers
Protect the
product from contamination with unwanted foreign materialsAnd
form the loss of contents during the use.
Air tight containers
are impermeable to solids,
liquids and gases during normal storage and use. If the container is to be
opened on more than one occasion it must remain airtight after reclosure.
Light resistant containers
Many pharmaceutical
products require light-resistant containers. In most instances, a container
made of a good quality of amber glass or a light-resistant opaque plastic will
reduce light transmission sufficiently to protect a light-sensitive
pharmaceutical. Agents termed ultraviolet (UV) absorbers may be added to
plastic to decrease the transmission of short UV rays. A recent innovation in
plastic packaging is the coextruded two-layer, high-density polyethylene
bottle, which has an inner layer of black polyethylene coextruded with an outer
layer of white polyethylene. The container provides light resistance (exceeding
amber glass) and moisture protection. It is increasingly being used in the
packaging of tablets and capsules.[12,13]
protect the contents
from the effect of radiation at a wavelength between 290nm and 150nm.
Closures[14,15]
The closure is normally the most vulnerable and critical component of a
container in so far as stability and compatibility with the product are
concerned. An effective closure must prevent the contents from escaping and
allow no substance to enter the container.
Function of
a closure:
·
Provide
a totally hermetic seal.
·
Provide
an effective seal which is acceptable to the products.
·
Provide
an effective microbiological seal.
Types of
closures
Closures are
available in five basic designs
·
threaded
screw cap
·
Lug
cap
·
Crimp-on
(crowns)
·
pilfer
proof closure
·
Roll-on
Many variations of
these basic types exist, including vacuum, tamperproof, safety, child
resistant, and liner less types, and dispenser applicators.
Threaded
Screw Cap:
The screw cap when
applied overcome the sealing surface irregularities and provides physical and
chemical protection to content being sealed. The screw cap is commonly made of
metal or plastics. The metal is usually tinplate or aluminum, and in plastics,
both thermoplastic and thermosetting materials are used.
Lug Cap:
The lug cap is
similar to the threaded screw cap and operates on the same principle. It is
simply an interrupted thread on the glass finish, instead of a continuous
thread. It is used to engage a lug on the cap sidewall and draw the cap down to
the sealing surface of the container. Unlike the threaded closure, it requires
only a quarter turn.The lug cap is used for both
normal atmospheric-pressure and vacuum-pressure closing.
Crown Caps:
This style of cap
is commonly used as a crimped closure for beverage bottles and has remained
essentially unchanged for more than 50 years.
Roll-On
Closures:
The aluminum roll-on cap can be sealed securely, opened easily, and resealed
effectively. It finds wide application in the packaging of food, beverages,
chemicals, and pharmaceuticals. The roll-on closure requires a material that is
easy to form, such as aluminum or other light-gauge metal. Re sealable, non re
sealable, and pilfer proof types of the roll-on closure are available for use
on glass or plastic bottles and jars.
Pilfer proof Closures:
The pilfer proof
closure is similar to the standard roll-on closure except that it has a greater
skirt length. This additional length extends below the threaded portion to form
a bank, which is fastened to the basic cap by a series of narrow metal
"bridges." When the pilfer proof closure is removed, the bridges
break, and the bank remains in place on the neck of the container. The closure
can be re sealed easily and the detached band indicates that the package has
been opened. The torque is necessary to remove the cap.
Suppositories package[16]
Bottle packing Plastic bottles and
these are sealed by aluminium taggers. Such bottles
are further packed in an e-flute carton which contains bottles. Such e-flute
cartons are then finally packed in to a master corrugated shipper. Strip packing Pouch type strip packing, these strips are of 4 ply material [poly+aluminium+poly+paper (inner layer poly and extreme
outer layer-paper)] strip pack is superior to
blister pack in the 3 ways ·
The
product i.e. suppository can be removed easily without breakage which happens
many times with blister pack. ·
Often
blister pack requires refrigeration to avoid deformity in shape this is not
the case in strip pack ·
Strip
pack is of 4 ply material including aluminium which
has better moisture barrier properties and hence the product is more stable
as compared to blister pack which is usually of pvc. UPVC FILM- (UNPLASTICISED
POLYVINYL CHLORIDE) Glossy white film for suppository packaging.PVC/PE/PVDC.
Packaged in a tamper resistant packaging. |
Hermetically
sealed borosilicate glass ampoules Provide a secure
environment for lipids sensitive to oxidation. The ampules
are shipped in cardboard liners for protection and storage convenience. Ampules are pre-scored for easier opening. Once the seal
is broken, sample may be transferred to a Screw Cap Storage Vial (see below). |
Narrow-mouth
borosilicate glass bottles |
Wide-mouth
borosilicate glass bottles |
The Screw Cap
Storage Vial |
Transdermal
patches packaging
Backing Film:
Occlusive
films of varied composition and/or thickness.
Adhesive:
An adhesive layer that
incorporates the active ingredient; featuring silicone, acrylic and/orpolyisobutylene adhesive formulations.
Release Liner:
Removable coated film or
polymer based protective layer.
CONCLUSION:
Packaging plays its most visible and catalytic role in a modern economy with
the widespread adoption of branding of products and development of consumer
preferences. to the extent that any consumer product
is packaging in a manner that meets the criteria of safety, convenience and
attractiveness. There is a lot of going in new packaging technologies. This
article has reviewed only a fraction of each area of packaging material in
pharmaceutical packaging.
AKNOWLEDGEMENTS:
All
the authors are thankful to Chalapathi Institute of Pharmaceutical
Sciences for providing
necessary facilities to bring out this work.
REFERENCES:
1 Jain UK, Nayak
S. 1st ed. Hyderabad: Pharma Med Press; 2008. Pharmaceutical
Packaging Technology; pp. 1–273.
2 Carter SJ. Copper and Gunn's
Packaging in Tutorial Pharmacy. 2005:133–41.
3 M.E. Aulton.
“The Science of Dosage Form Design”, Secondedition.pageno:554-570
4 World Health Organization, 2002. Guidelines
on packaging for pharmaceutical Product, Annex 9, 2002.tests on biodegradable
plastic materials. (WHO Technical Report Series, No. 902).
5 (WHO Technical Report Series, No. 902) http://www.who.int/ medicines/areas
/quality assurance/regulatory standards/en/index html
6 World Health Organization. Annex 9, Guidelines on packaging for
pharmaceutical products, WHO Technical Report Series, No. 902, 2002.
7 Good manufacturing practices for pharmaceutical products. In:
WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Thirty-second report. Geneva, World Health Organization, 1992, Annex 1 (WHO
Technical Report Series, No. 823).
8 Trends in pharmaceutical
packaging. [Last accessed on 2001 Oct 19]. Available from:http://www.ngpharma.eu.com/article/Trends-in-pharmaceutical-packaging
9 Matthew S. Thomas Associate Senior Consultant Engineer,
Pharmaceutical Packaging Development, Eli Lilly and Company October 2nd, 2010
10 Manoi, Shekhawati College of pharmacy, Dundlod. Pharmatutor. Review on: the pharmaceutical packaging
11 Availableonline
http://www.ipharmsciencia.com.Internationale Pharmaceutica
Sciencia 2012; 2:2.
12 Michael
J. Akers, PhD. http://www.pharmpress.com/ files/docs/Remington_Ch_26.pdf,
Sample chapter from Remington:
Essentials of Pharmaceutics, Parenteral
Preparations pg no 495-532
13 Packaging/Container Issues: Unit-dose, Pre-filled
Syringes, Pre-packs, Etc. International journal of pharmaceutical compounding.2011;1: 6
14 Mehta Kunal
C, Akhilesh.D and Shyam Kumar.B, Recent Trends in Pharmaceutical Packaging: A
review. International journal of pharmaceutical and chemical sciences .2012; 1:3. pg no:
932-944
15 Devi KV, Burande
M, Deepak H, Jobanputra SB. Packaging solutions to
the changing pharma market needs. Pharma Times. 2007; 39:29–34.
16 .http://www.meridianentp.com/product-sub/meridian_newsuppository.php.suppository packaging
17 http://avantilipids.com/index.php?view=itemsandcid=
5andid=13andoption=com_quickfaqandItemid=385.Packaging
for liposome’s
Received on 02.07.2014 Accepted on 05.08.2014
© Asian Pharma
Press All Right Reserved
Asian J. Res.
Pharm. Sci. 4(3):
July-Sept. 2014; Page 140-150